Tandem Diabetes Care (TNDM) Change in Acquisitions & Divestments (2014 - 2026)

Tandem Diabetes Care (TNDM) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $27.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 58.58% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.0 million (down 23.94% YoY) and the FY2025 annual result came in at $257.1 million, down 16.12% from the prior year.
• Change in Acquisitions & Divestments declined to $27.0 million in Q1 2026, from $56.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $166.4 million in Q3 2022 to a low of $27.0 million in Q1 2026.
• A 5-year average of $100.4 million and a median of $96.4 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 215.56% in 2022, down 59.07% in 2022.
• Tracing TNDM's Change in Acquisitions & Divestments over 5 years: stood at $146.6 million in 2022, then fell by 10.81% to $130.7 million in 2023, then plunged by 48.42% to $67.4 million in 2024, then dropped by 16.23% to $56.5 million in 2025, then tumbled by 52.29% to $27.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $27.0 million (Q1 2026), $56.5 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.